PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.16%
Net income growth under 50% of MCHP's 168.03%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.09%
Some D&A expansion while MCHP is negative at -54.33%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
600.00%
Well above MCHP's 78.58% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-22.53%
Negative yoy working capital usage while MCHP is 192.57%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth while MCHP is negative at -100.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
16.46%
Inventory shrinking or stable vs. MCHP's 139.67%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-100.00%
Negative yoy AP while MCHP is 100.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-2988.89%
Negative yoy usage while MCHP is 109.51%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
28.75%
Operating cash flow growth above 1.5x MCHP's 14.00%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
11.22%
Some CapEx rise while MCHP is negative at -5.08%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-14.43%
Both yoy lines negative, with MCHP at -8.02%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
13.68%
We have some liquidation growth while MCHP is negative at -2.96%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-100.00%
We reduce yoy other investing while MCHP is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
7.96%
We have mild expansions while MCHP is negative at -27.14%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
64.29%
Lower share issuance yoy vs. MCHP's 179.66%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
34.30%
Buyback growth below 50% of MCHP's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.